Innoviva Historical Financial Ratios
| INVA Stock | USD 17.55 0.10 0.57% |
Innoviva is lately reporting on over 110 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.63 or Days Sales Outstanding of 93.9 will help investors to properly organize and evaluate Innoviva financial condition quickly.
Innoviva |
About Innoviva Financial Ratios Analysis
InnovivaFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Innoviva investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Innoviva financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Innoviva history.
Innoviva Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Innoviva stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Innoviva sales, a figure that is much harder to manipulate than other Innoviva multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Innoviva dividend as a percentage of Innoviva stock price. Innoviva dividend yield is a measure of Innoviva stock productivity, which can be interpreted as interest rate earned on an Innoviva investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Operating Cash Flow Per Share
A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Innoviva's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Innoviva current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.At present, Innoviva's PTB Ratio is projected to slightly grow based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 10.83, whereas Price To Sales Ratio is forecasted to decline to 3.21.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 22.61 | 23.7 | 25.25 | 28.92 | Receivables Turnover | 3.54 | 5.17 | 3.69 | 3.51 |
Innoviva fundamentals Correlations
Click cells to compare fundamentals
Innoviva Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Innoviva fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 5.49 | 3.73 | 3.61 | 2.79 | 3.38 | 3.21 | |
| Ptb Ratio | 11.46 | 4.57 | 2.33 | 3.41 | 1.63 | 1.56 | |
| Days Sales Outstanding | 111.07 | 101.8 | 103.12 | 70.58 | 98.84 | 93.9 | |
| Book Value Per Share | 3.38 | 6.0 | 6.41 | 8.12 | 10.31 | 10.83 | |
| Free Cash Flow Yield | 0.13 | 0.18 | 0.25 | 0.26 | 0.22 | 0.14 | |
| Operating Cash Flow Per Share | 2.55 | 3.09 | 4.43 | 2.9 | 2.16 | 2.26 | |
| Stock Based Compensation To Revenue | 0.007877 | 0.005042 | 0.005147 | 0.0222 | 0.0188 | 0.0179 | |
| Pb Ratio | 11.46 | 4.57 | 2.33 | 3.41 | 1.63 | 1.56 | |
| Ev To Sales | 5.87 | 4.14 | 4.11 | 3.83 | 4.2 | 3.99 | |
| Free Cash Flow Per Share | 2.55 | 3.09 | 4.42 | 2.9 | 2.15 | 2.26 | |
| Roic | 0.33 | 0.86 | 0.29 | 0.38 | 0.15 | 0.18 | |
| Net Income Per Share | 1.55 | 2.21 | 4.49 | 3.07 | 2.75 | 2.88 | |
| Sales General And Administrative To Revenue | 0.0561 | 0.0412 | 0.0413 | 0.19 | 0.22 | 0.21 | |
| Cash Per Share | 3.47 | 2.43 | 2.46 | 4.18 | 2.96 | 4.8 | |
| Pocfratio | 5.56 | 4.01 | 3.89 | 4.57 | 7.44 | 7.81 | |
| Interest Coverage | 13.2 | 17.52 | 19.67 | 13.3 | 9.22 | 9.69 | |
| Pfcf Ratio | 5.56 | 4.01 | 3.9 | 4.58 | 7.46 | 7.84 | |
| Income Quality | 0.55 | 1.35 | 1.07 | 0.99 | 0.92 | 0.82 | |
| Roe | 0.5 | 0.42 | 0.89 | 0.38 | 0.27 | 0.26 | |
| Ev To Operating Cash Flow | 5.95 | 4.45 | 4.42 | 6.29 | 9.25 | 9.71 | |
| Pe Ratio | 9.11 | 5.59 | 3.84 | 4.31 | 5.84 | 6.13 | |
| Return On Tangible Assets | 0.72 | 0.22 | 0.26 | 0.45 | 0.18 | 0.19 | |
| Ev To Free Cash Flow | 5.95 | 4.45 | 4.44 | 6.3 | 9.28 | 9.74 | |
| Earnings Yield | 0.22 | 0.11 | 0.18 | 0.26 | 0.23 | 0.17 | |
| Net Debt To E B I T D A | 1.29 | 0.37 | 0.36 | 0.4 | 1.08 | 1.03 | |
| Current Ratio | 80.29 | 55.98 | 54.02 | 11.44 | 9.03 | 13.85 | |
| Tangible Book Value Per Share | 3.38 | 4.76 | 5.05 | 4.11 | 6.52 | 6.85 | |
| Receivables Turnover | 3.29 | 3.59 | 3.54 | 5.17 | 3.69 | 3.51 | |
| Graham Number | 10.41 | 16.3 | 22.61 | 23.7 | 25.25 | 28.92 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Innoviva offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innoviva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innoviva Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innoviva Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innoviva. If investors know Innoviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innoviva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.98) | Earnings Share 0.8 | Revenue Per Share 5.6 | Quarterly Revenue Growth 0.331 | Return On Assets 0.0937 |
The market value of Innoviva is measured differently than its book value, which is the value of Innoviva that is recorded on the company's balance sheet. Investors also form their own opinion of Innoviva's value that differs from its market value or its book value, called intrinsic value, which is Innoviva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innoviva's market value can be influenced by many factors that don't directly affect Innoviva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innoviva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innoviva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innoviva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.